These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6820922)

  • 1. [Characterization and bioactivity of interferon induced by Streptococcus faecalis preparation, TH69].
    Yamaguchi T; Saito M; Kuroda Y; Ebina T; Ishida N; Hoshino F; Kawade Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1609-16. PubMed ID: 6820922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and interferon-inducing activities of TH69, a whole bacterial preparation of Streptococcus faecalis, in mice.
    Abe N; Yamaguchi T; Hoshino F; Suzuki F; Ebina T; Ishida N
    Gan; 1982 Oct; 73(5):811-8. PubMed ID: 6819977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune interferon production by TH69, a lyophilized preparation of Streptococcus faecalis, in murine spleen cell cultures.
    Yamaguchi T; Kuroda Y; Saito M; Ebina T; Hoshino F; Ishida N
    Microbiol Immunol; 1984; 28(5):601-10. PubMed ID: 6433156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells.
    Ojo-Amaize EA; Vilcek J; Cochrane AH; Nussenzweig RS
    J Immunol; 1984 Aug; 133(2):1005-9. PubMed ID: 6429240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages.
    Ramarathinam L; Niesel DW; Klimpel GR
    J Immunol; 1993 May; 150(9):3973-81. PubMed ID: 8473744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.
    Sher A; Oswald IP; Hieny S; Gazzinelli RT
    J Immunol; 1993 May; 150(9):3982-9. PubMed ID: 8473745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
    Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
    Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.